Effect of No Decay tablet used for lowering the bacteria causing tooth decay
Phase 4
- Registration Number
- CTRI/2021/11/037791
- Lead Sponsor
- Department of Pedodontics and Preventive Dentistry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Healthy children between ages 12- 18 years of age.
High caries risk patients according to caries risk assessment form.
Exclusion Criteria
Children in low and moderate risk category.
Children with known egg allergy
Medically compromised patients
Patients with history of antibiotics intake thirty days prior or during the course of the study
Children whose parents refused to give consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To estimate the count of S. mutans in saliva pre and post <br/ ><br>administration of Ig Y tablets. <br/ ><br>Timepoint: Saliva collection and microbial analysis will be carried out at four intervals ,i.e. before the administration, and on 15th , 30th and 60th day after administration
- Secondary Outcome Measures
Name Time Method To evaluate the effect of Ig Y tablets on salivary pHTimepoint: Salivary pH will be recorded at 0, 16th , 30th and 60th day